These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23097583)

  • 1. Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapy.
    Bunders MJ; Frinking O; Scherpbier HJ; van Arnhem LA; van Eck-Smit BL; Kuijpers TW; Zwinderman AH; Reiss P; Pajkrt D
    Clin Infect Dis; 2013 Feb; 56(4):583-6. PubMed ID: 23097583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir disoproxil fumarate and bone mineral density: a 60-month longitudinal study in a cohort of HIV-infected youths.
    Viganò A; Zuccotti GV; Puzzovio M; Pivetti V; Zamproni I; Cerini C; Fabiano V; Giacomet V; Mora S
    Antivir Ther; 2010; 15(7):1053-8. PubMed ID: 21041922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
    Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies link HIV drugs and bone density problems. Research examining HIV in children and women.
    AIDS Alert; 2003 Jul; 18(7):88-9. PubMed ID: 12846197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART).
    Bolland MJ; Grey A; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Gamble GD; Reid IR
    Clin Endocrinol (Oxf); 2012 May; 76(5):643-8. PubMed ID: 22040002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable bone density in HAART-treated individuals with HIV: a meta-analysis.
    Bolland MJ; Wang TK; Grey A; Gamble GD; Reid IR
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2721-31. PubMed ID: 21715534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
    Madeddu G; Spanu A; Solinas P; Calia GM; Lovigu C; Chessa F; Mannazzu M; Falchi A; Mura MS; Madeddu G
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):39-48. PubMed ID: 15195003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decreased bone mineral density in HIV-infected children receiving highly active antiretroviral therapy].
    Rojo Conejo P; Ramos Amador JT; García Piñar L; Ruano Fajardo C; Sánchez Granados JM; González Tomé MI; Ruiz Contreras J
    An Pediatr (Barc); 2004 Mar; 60(3):249-53. PubMed ID: 14987516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.
    van Vonderen MG; Lips P; van Agtmael MA; Hassink EA; Brinkman K; Geerlings SE; Sutinen J; Ristola M; Danner SA; Reiss P
    AIDS; 2009 Jul; 23(11):1367-76. PubMed ID: 19424051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
    Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.
    Kline MW; Rugina S; Ilie M; Matusa RF; Schweitzer AM; Calles NR; Schwarzwald HL
    Pediatrics; 2007 May; 119(5):e1116-20. PubMed ID: 17420261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone changes and fracture risk in individuals infected with HIV.
    Warriner AH; Mugavero MJ
    Curr Rheumatol Rep; 2010 Jun; 12(3):163-9. PubMed ID: 20425517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bone mineral density in Iranian HIV/AIDS patients.
    Badie BM; Soori T; Kheirandish P; Izadyar S; SeyedAlinagh S; Foroughi M; Rostamian A; Mohraz M
    Acta Med Iran; 2011; 49(7):460-7. PubMed ID: 21960080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy.
    Fraaij PL; Verweel G; van Rossum AM; van Lochem EG; Schutten M; Weemaes CM; Hartwig NG; Burger DM; de Groot R
    Clin Infect Dis; 2005 Feb; 40(4):604-8. PubMed ID: 15712085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy.
    Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Mannazzu M; Falchi A; Sanna D; Mura MS; Madeddu G
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):290-301. PubMed ID: 18596668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and bone disease: implications for an aging population.
    Cotter AG; Mallon PW
    Sex Health; 2011 Dec; 8(4):493-501. PubMed ID: 22127034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone disorders in human immunodeficiency virus infection.
    Glesby MJ
    Clin Infect Dis; 2003; 37 Suppl 2():S91-5. PubMed ID: 12942380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral abnormalities in persons with HIV infection: signal or noise?
    Singh K; Moyle GJ
    AIDS Read; 2006 Aug; 16(8):407-10, 413-8. PubMed ID: 16933375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.